‘How to be an early-stage Biotech CEO in challenging times’, cited by Citeline – Duplicate – [#1444]
Our Co-founder, Malcolm Silander, chaired the discussion which formed the basis of Andrew McConaghie’s (In Vivo / Citeline) recent article, ‘How to be an early-stage Biotech CEO in challenging times’.
Precision BioSearch expands C-suite team of SENISCA with COO and CDO appointments – Duplicate – [#1430]
Precision BioSearch partnered with SENISCA, an award-winning biotechnology company developing RNA based therapeutics to reverse cellular senescence and target age-related disease
Biotech investment has taken a considerable downward turn over the past 18 months, impacted by the global macroeconomic situation and a return to lower levels of funding post-pandemic.